News | April 08, 2023
Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
